Category Archives : Drug Repositioning


Consider all the other Marketing P’s — there is more than “product” in life cycle planning

Remember to look at more than just the “product” in life cycle planning. Consider all the other Marketing P’s: – Place (distribution) – Price (contracts, incentives) – Promotion (unique channels) – Packaging (novel, convenient) – Put-ups (sizes, kits, bundles) – Personal support (services offerings) – Professional development (education, training, certification)


3 benefits of drug repositioning – and the application of Strategic GPS®

A number of studies have shown that in the last 10 to 15 years, while R&D spending has steadily increased, the number of drugs making it to the market has not followed pace.  That’s why the advantages of drug positioning hold such allure. The key advantage of the drug repositioning approach is that it reduces the time, cost, and risk compared with de novo development. As well as providing an advantage to companies, it also provides an advantage to patients, because it reduces the overall cost by rescuing the investment in failed drugs and makes safer and more effective drugs […]